Nantahala Capital Management’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,575,021
| Closed | -$45.4M | – | 145 |
|
|
2023
Q1 | $45.4M | Buy |
4,575,021
+518,394
| +13% | +$5.13M | 3.48% | 7 |
|
|
2022
Q4 | $40.4M | Buy |
4,056,627
+82,721
| +2% | +$617K | 2.62% | 8 |
|
|
2022
Q3 | $21.9M | Buy |
3,973,906
+250,896
| +7% | +$1.39M | 1.42% | 24 |
|
|
2022
Q2 | $13.6M | Sell |
3,723,010
-1,889
| -0.1% | -$8.93K | 0.68% | 37 |
|
|
2022
Q1 | $22.5M | Sell |
3,724,899
-36,884
| -1% | -$225K | 1% | 27 |
|
|
2021
Q4 | $31.7M | Buy |
3,761,783
+1,247,455
| +50% | +$10.9M | 1.12% | 27 |
|
|
2021
Q3 | $22.8M | Buy |
2,514,328
+196,837
| +8% | +$1.69M | 0.72% | 37 |
|
|
2021
Q2 | $18.8M | Buy |
2,317,491
+37,521
| +2% | +$257K | 0.53% | 46 |
|
|
2021
Q1 | $12.6M | Sell |
2,279,970
-9,293
| -0.4% | -$46K | 0.37% | 55 |
|
|
2020
Q4 | $7.78M | Buy |
2,289,263
+375,291
| +20% | +$988K | 0.24% | 79 |
|
|
2020
Q3 | $3.23M | Buy |
1,913,972
+65,300
| +4% | +$98.5K | 0.1% | 90 |
|
|
2020
Q2 | $3.02M | Hold |
1,848,672
| – | – | 0.09% | 96 |
|
|
2020
Q1 | $3.55M | Buy |
1,848,672
+38,110
| +2% | +$100K | 0.13% | 80 |
|
|
2019
Q4 | $5.28M | Hold |
1,810,562
| – | – | 0.16% | 67 |
|
|
2019
Q3 | $5.96M | Hold |
1,810,562
| – | – | 0.22% | 66 |
|
|
2019
Q2 | $5.88M | Sell |
1,810,562
-100,000
| -5% | -$356K | 0.18% | 71 |
|
|
2019
Q1 | $7.15M | Buy |
1,910,562
+150,000
| +9% | +$525K | 0.22% | 61 |
|
|
2018
Q4 | $6.07M | Buy |
1,760,562
+568,577
| +48% | +$2.81M | 0.19% | 71 |
|
|
2018
Q3 | $8.55M | Buy |
1,191,985
+542,044
| +83% | +$4.21M | 0.23% | 61 |
|
|
2018
Q2 | $4.54M | Buy |
+649,941
| New | +$4.04M | 0.18% | 70 |
|
Nantahala Capital Management's APEN Position: Q2 2023 in Review
Nantahala Capital Management sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 4,575,021 shares — an estimated $45.4M sold.
Nantahala Capital Management first reported a position in APEN in Q2 2018 and held it in 20 quarters. The position peaked at $45.4M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- Nantahala Capital Management reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- Nantahala Capital Management sold 4,575,021 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $45.4M.
- Nantahala Capital Management first reported a position in Apollo Endosurgery, Inc. in Q2 2018 and held it in 20 quarters.
- Nantahala Capital Management's Apollo Endosurgery, Inc. position peaked at $45.4M in Q1 2023.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on Nantahala Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.